Literature DB >> 15967459

Patterned CpG methylation of silenced B cell gene promoters in classical Hodgkin lymphoma-derived and primary effusion lymphoma cell lines.

Jeanette R Doerr1, Cindy S Malone, Francesca M Fike, Melinda S Gordon, Shahe V Soghomonian, Roman K Thomas, Qian Tao, Paul G Murray, Volker Diehl, Michael A Teitell, Randolph Wall.   

Abstract

Hodgkin and Reed-Sternberg (HRS) cells of classical Hodgkin lymphoma (cHL) and primary effusion lymphoma (PEL) are derived from germinal center (GC) and post-GC B cells, respectively. Neither express many of the B cell genes or surface markers typically expressed by other GC-derived B cell lymphomas or normal B cells. This loss of B cell gene expression is not due to a lack of essential transcription factors, as studies have shown that the ectopic expression of missing transcription factors failed to reactivate endogenous target genes. These results implicate epigenetic mechanisms extinguishing B cell gene expression. Silenced endogenous B cell genes representing a surface receptor, B29 (Igbeta, CD79b), a signaling molecule, TCL1, and a transcription factor, Bob1 (OCA-B, OBF-1), were reactivated by 5-aza-2'-deoxycytidine, indicating that gene silencing in HRS and PEL cells is due to DNA methylation. Genomic bisulfite sequencing corroborated this prediction and revealed three distinct patterns of methylation for the silenced B29 and TCL1 promoters. These distinct patterns consisted of 5' promoter CpG methylation alone, 5' and 3' promoter CpG methylation sparing sites in the central cores, and complete CpG methylation throughout the promoter regions. The silenced Bob1 promoter showed one pattern of dense CpG methylation at essentially all sites. These consistent patterns predict that, although gene silencing in many HRS and PEL cells mimics appropriate gene silencing, in some cases of complete CpG methylation throughout entire promoters both the activation and targeting of methylation is abnormal.

Entities:  

Mesh:

Year:  2005        PMID: 15967459     DOI: 10.1016/j.jmb.2005.05.032

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  13 in total

1.  Nutrients and genetic variation involved in one-carbon metabolism and Hodgkin lymphoma risk: a population-based case-control study.

Authors:  Julie L Kasperzyk; Ellen T Chang; Brenda M Birmann; Peter Kraft; Tongzhang Zheng; Nancy E Mueller
Journal:  Am J Epidemiol       Date:  2011-08-01       Impact factor: 4.897

2.  Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma.

Authors:  Jessica A Shafer; Conrad R Cruz; Ann M Leen; Stephanie Ku; An Lu; Alexandra Rousseau; Helen E Heslop; Cliona M Rooney; Catherine M Bollard; Aaron E Foster
Journal:  Leuk Lymphoma       Date:  2010-05

3.  Methylation profiling of mediastinal gray zone lymphoma reveals a distinctive signature with elements shared by classical Hodgkin's lymphoma and primary mediastinal large B-cell lymphoma.

Authors:  Franziska C Eberle; Jaime Rodriguez-Canales; Lai Wei; Jeffrey C Hanson; J Keith Killian; Hong-Wei Sun; Lisa G Adams; Stephen M Hewitt; Wyndham H Wilson; Stefania Pittaluga; Paul S Meltzer; Louis M Staudt; Michael R Emmert-Buck; Elaine S Jaffe
Journal:  Haematologica       Date:  2011-04       Impact factor: 9.941

4.  B29 gene silencing in pituitary cells is regulated by its 3' enhancer.

Authors:  Cindy S Malone; Ali I Kuraishy; Francesca M Fike; Ruchika G Loya; Minil R Mikkili; Michael A Teitell; Randolph Wall
Journal:  J Mol Biol       Date:  2006-07-28       Impact factor: 5.469

5.  Potential role of hypoxia in early stages of Hodgkin lymphoma pathogenesis.

Authors:  Frederik Wein; Teresa Otto; Pascal Lambertz; Joachim Fandrey; Martin-Leo Hansmann; Ralf Küppers
Journal:  Haematologica       Date:  2015-07-09       Impact factor: 9.941

6.  Classical Hodgkin's lymphoma shows epigenetic features of abortive plasma cell differentiation.

Authors:  Volkhard Seitz; Philippe E Thomas; Karin Zimmermann; Ulrike Paul; Anke Ehlers; Maria Joosten; Lora Dimitrova; Dido Lenze; Anke Sommerfeld; Elisabeth Oker; Ulf Leser; Harald Stein; Michael Hummel
Journal:  Haematologica       Date:  2011-03-10       Impact factor: 9.941

7.  The importance of epigenetic alterations in the development of epstein-barr virus-related lymphomas.

Authors:  Maria Takacs; Judit Segesdi; Ferenc Banati; Anita Koroknai; Hans Wolf; Hans Helmut Niller; Janos Minarovits
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-11-15       Impact factor: 2.576

Review 8.  The biology of Hodgkin's lymphoma.

Authors:  Ralf Küppers
Journal:  Nat Rev Cancer       Date:  2008-12-11       Impact factor: 60.716

9.  Epigenetic silencing of Stk39 in B-cell lymphoma inhibits apoptosis from genotoxic stress.

Authors:  Cynthia E Balatoni; David W Dawson; Jane Suh; Mara H Sherman; Grant Sanders; Jason S Hong; Matthew J Frank; Cindy S Malone; Jonathan W Said; Michael A Teitell
Journal:  Am J Pathol       Date:  2009-08-28       Impact factor: 4.307

10.  Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B5b (CYB5B).

Authors:  Derek Murphy; Jeremy Parker; Minglong Zhou; Faisal M Fadlelmola; Christian Steidl; Aly Karsan; Randy D Gascoyne; Hong Chen; Diponkar Banerjee
Journal:  Mol Cancer       Date:  2010-01-26       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.